CENTRE ANTOINE LACASSAGNE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
77
Active:20
Completed:32
Trial Phases
4 Phases
Phase 1:16
Phase 2:8
Phase 3:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (64 trials with phase data)• Click on a phase to view related trials
Not Applicable
36 (56.3%)Phase 1
16 (25.0%)Phase 2
8 (12.5%)phase_1_2
2 (3.1%)Phase 3
2 (3.1%)Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
Not Applicable
Recruiting
- Conditions
- Cancer
- First Posted Date
- 2025-02-28
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 40000
- Registration Number
- NCT06851975
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
Recruiting
- Conditions
- Carcinoma, Non-Small-Cell Lung (NSCLC)
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 200
- Registration Number
- NCT06833229
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Development of Preclinical Models Derived From Tumors With a Molecular Abnormality of Interest to Test Their Sensitivity to New Anti-tumor Therapies.
Not Applicable
Recruiting
- Conditions
- Neoplasm Malignant
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 50
- Registration Number
- NCT06782451
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost
Phase 2
Recruiting
- Conditions
- Carcinoma, Non-Small-Cell Lung
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 37
- Registration Number
- NCT06627738
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Study on the Contribution of the Genetic Tumor Profile Obtained Through Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA
Not Applicable
Recruiting
- Conditions
- Neoplasm Malignant
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 238
- Registration Number
- NCT06606366
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
News
No news found